The effect of combined treatment to reduce body dysmorphic disorder in wome

Phase 2

• Conditions: F45.22; Body dysmorphic disorder.; Body dysmorphic disorder

• Registration Number: IRCT20220730055583N1
• Lead Sponsor: Vice President of Research and Technology of Ferdowsi University of Mashhad Ferdowsi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 3

Inclusion Criteria

Being women
Body dysmorphic disorder
Age between 20 and 50 years old

Exclusion Criteria

Intellectual disability

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body deformity disorder. Timepoint: At the beginning of the study and 3, 6, 9, 13 and 16 weeks after the start of the treatment. Method of measurement: content analysis.